What are some of the organisms that cause pneumonia? What is the treatment for pneumonia? Can pneumonia be prevented?
The most common cause of a bacterial pneumonia is
Streptococcus pneumoniae. In this form of pneumonia, there is usually an abrupt onset of the illness with shaking chills, fever, and production of a rust-colored sputum. The infection spreads into the blood in 20%-30% of cases
(known as sepsis), and if this occurs, 20%-30% of these patients die.
Two vaccines are available to prevent pneumococcal disease: the pneumococcal conjugate vaccine
(PCV13) and the pneumococcal polysaccharide vaccine (PPV23; Pneumovax).
The pneumococcal conjugate vaccine is part of the routine infant
immunization schedule in the U.S. and is recommended for all children
< 2 years of age and children 2-4 years of age who have certain
medical conditions. The pneumococcal polysaccharide vaccine is
recommended for adults at increased risk for developing pneumococcal
pneumonia including the elderly, people who have diabetes, chronic heart, lung, or kidney disease, those with alcoholism, cigarette smokers, and in those people who have had their spleen removed. This vaccination should be repeated every
five to seven years, whereas the flu vaccine is given annually.
Antibiotics often used in the treatment of this type of pneumonia include penicillin, amoxicillin and clavulanic acid (Augmentin, Augmentin XR), and macrolide antibiotics including erythromycin (E-Mycin, Eryc, Ery-Tab, PCE, Pediazole, Ilosone), azithromycin (Zithromax,
Z-Max), and clarithromycin
(Biaxin). Penicillin was formerly the antibiotic of choice in treating
this infection. With the advent and widespread use of broader-spectrum
antibiotics, significant drug resistance has developed. Penicillin may
still be effective in treatment of pneumococcal pneumonia, but it should
only be used after cultures of the bacteria confirm their sensitivity
to this antibiotic.
Klebsiella pneumoniae and
Hemophilus influenzae are bacteria that often cause pneumonia in people suffering from chronic obstructive pulmonary disease (COPD) or alcoholism. Useful antibiotics in this case are the second- and third-generation cephalosporins, amoxicillin and clavulanic acid, fluoroquinolones (levofloxacin [Levaquin], moxifloxacin-oral
[Avelox], and sulfamethoxazole/trimethoprim
[Bactrim, Septra]).
Mycoplasma pneumoniae is a type of bacteria that often causes a
slowly developing infection. Symptoms include fever, chills, muscle aches,
diarrhea, and rash. This bacterium is the principal cause of many pneumonias in
the summer and fall months, and the condition often referred to as "atypical
pneumonia." Macrolides (erythromycin, clarithromycin, azithromycin, and
fluoroquinolones) are antibiotics commonly prescribed to treat
Mycoplasma
pneumonia.
Legionnaire's disease is caused by the bacterium
Legionella pneumoniae
that is most often found in contaminated water supplies and air conditioners. It
is a potentially fatal infection if not accurately diagnosed. Pneumonia is part
of the overall infection, and symptoms include high fever, a relatively slow
heart rate, diarrhea, nausea, vomiting, and chest pain. Older men, smokers, and
people whose immune systems are suppressed are at higher risk of developing
Legionnaire's disease. Fluoroquinolones (see above) are the treatment of choice in this
infection. This infection is often diagnosed by a special urine test looking for
specific antibodies to the specific organism.
Mycoplasma, Legionnaire's, and another infection,
Chlamydia pneumoniae,
all cause a syndrome known as "atypical pneumonia." In this syndrome,
the chest X-ray shows diffuse abnormalities, yet the patient does not
appear severely ill. In the past, this condition was referred to as "walking
pneumonia," a term that is rarely used today. These infections are very
difficult to distinguish clinically and often require laboratory
evidence for confirmation.
Recently, a study performed in the Netherlands demonstrated that adding a steroid medication, dexamethasone
(Decadron), to antibiotic therapy shortens the duration of
hospitalization. This medication should be used with caution in patients
whom are critically ill or already have a compromised immune system.
Pneumocystis carinii (now known as
Pneumocystis jiroveci) pneumonia is another form of pneumonia
that usually involves both lungs. It is seen in patients with a compromised
immune system, either from chemotherapy for cancer, HIV/AIDS, and those treated
with TNF (tumor necrosis factor), such as for rheumatoid arthritis. Once
diagnosed, it usually responds well to sulfa-containing antibiotics. Steroids
are often additionally used in more severe cases.
Viral pneumonias do not typically respond to antibiotic treatment. These
infections can be caused by adenoviruses, rhinovirus, influenza virus (flu),
respiratory syncytial virus (RSV), and parainfluenza virus (that also causes
croup).
These pneumonias usually resolve over time with the body's immune
system
fighting off the infection. It is important to make sure that a
bacterial
pneumonia does not secondarily develop. If it does, then the bacterial
pneumonia
is treated with appropriate antibiotics. In some situations, antiviral
therapy is
helpful in treating these conditions. More recently, H1N1, swine-origin
influenza A, has been associated with very severe pneumonia often
resulting in respiratory failure. This disease often requires the use
of mechanical ventilation for breathing support. Death is not uncommon
when this infection involves the lungs.
Fungal infections that can lead to pneumonia include histoplasmosis,
coccidiomycosis, blastomycosis,
aspergillosis, and cryptococcosis. These are
responsible for a relatively small percentage of pneumonias in the United
States. Each fungus has specific antibiotic treatments, among which are
amphotericin B, fluconazole (Diflucan), penicillin, and sulfonamides.
Major concerns have developed in the medical community regarding the overuse
of antibiotics. Most sore throats and upper respiratory infections are caused by
viruses rather than bacteria. Though antibiotics are ineffective against
viruses, they are often prescribed. This excessive use has resulted in a variety
of bacteria that have become resistant to many antibiotics. These resistant
organisms are commonly seen in hospitals and nursing homes. In fact, physicians
must consider the location when prescribing antibiotics (community-acquired
pneumonia, or CAP, versus hospital-acquired pneumonia, or HAP).
The more virulent organisms often come from the health-care environment,
either the hospital or nursing homes. These organisms have been exposed to a
variety of the strongest antibiotics that we have available. They tend to
develop resistance to some of these antibiotics. These organisms are referred to
as nosocomial bacteria and can cause what is known as nosocomial pneumonia when
the lungs become infected.
Recently, one of these resistant organisms from the hospital has become quite
common in the community. In some communities, up to 50% of
Staph aureus
infections are due to organisms resistant to the antibiotic methicillin. This
organism is referred to as MRSA (methicillin-resistant
Staph aureus)
and
requires special antibiotics when it causes infection. It can cause
pneumonia
but also frequently causes skin infections. In many hospitals, patients
with
this infection are placed in contact isolation. Their visitors are often
asked
to wear gloves, masks, and gowns. This is done to help prevent the
spread of
this bacteria to other surfaces where they can inadvertently contaminate
whatever touches that surface. It is therefore very important to wash
your hands
thoroughly and frequently to limit further spread of this resistant
organism. The situation with MRSA continues to evolve. The
community-acquired strain of MRSA tends to be responsive to some of the
more commonly used antibiotics whereas the hospital-acquired strains
require stronger, more aggressive antibiotic therapies. As this
evolution occurs, patients are arriving in the hospital with the
community-acquired strains as well as a previous hospital-acquired
strain. This further necessitates performing bacterial cultures to
determine the best course of action.